Search results for "FOS"

showing 10 items of 15075 documents

Cost-effectiveness of sofosbuvir-based triple therapy for untreated patients with genotype 1 chronic hepatitis C

2014

We assessed the cost-effectiveness of sofosbuvir (SOF)-based triple therapy (TT) compared with boceprevir (BOC)- and telaprevir (TVR)-based TT in untreated genotype 1 (G1) chronic hepatitis C (CHC) patients discriminated according to IL28B genotype, severity of liver fibrosis, and G1 subtype. The available published literature provided the data source. The target population was made up of untreated Caucasian patients, aged 50 years, with G1CHC and these were evaluated over a lifetime horizon by Markov model. The study was carried out from the perspective of the Italian National Health Service. Outcomes included discounted costs (in euros at 2013 value), life-years gained (LYG), quality-adju…

medicine.medical_specialtyCirrhosisHepatologySofosbuvirCost effectivenessbusiness.industryHepatologymedicine.diseaseSurgeryQuality-adjusted life yearTelaprevirchemistry.chemical_compoundTolerabilitychemistryBoceprevirInternal medicinemedicinebusinesshealth care economics and organizationsmedicine.drugHepatology
researchProduct

Facial nerve schwannoma involving middle cranial fossa: When the unilateral sensorineural hearing loss guide to the correct diagnosis

2011

The Facial Nerve Schwannoma is a rare tumor and it seldom involved the middle cranial fossa. Facial nerve schwannoma has various manifestations, including facial palsy but unfortunately facial nerve is very resistant to compression and often facial nerve paralysis or a facial weakness are not present. We present a case of giant facial nerve schwannoma involved the middle cranial fossa without facial nerve paralysis. In these cases the unilateral hearing loss (if present) guide to a correct diagnosis.

medicine.medical_specialtyClinical ReportPalsybusiness.industryFacial weaknessFacial nerve paralysisSchwannomaMiddle cranial fossaMiddle cranial fossamedicine.diseaseFacial nerveFacial nerveSurgerystomatognathic diseasesmedicine.anatomical_structureOtorhinolaryngologyDiagnosisotorhinolaryngologic diseasesmedicineParalysisSurgerySensorineural hearing lossmedicine.symptomUnilateral hearing lossbusiness
researchProduct

Technical and surgical aspects of the sphenopalatine ganglion (SPG) microstimulator insertion procedure

2015

Cluster headache (CH) is a debilitating, severe form of headache. A novel non-systemic therapy has been developed that produces therapeutic electrical stimulation to the sphenopalatine ganglion (SPG). A transoral surgical technique for inserting the Pulsante SPG Microstimulator into the pterygopalatine fossa (PPF) is presented herein. Technical aspects include detailed descriptions of the preoperative planning using computed tomography or cone beam computed tomography scans for presurgical digital microstimulator insertion into the patient specific anatomy and intraoperative verification of microstimulator placement. Surgical aspects include techniques to insert the microstimulator into the…

medicine.medical_specialtyCone beam computed tomographymedicine.medical_treatmentPterygopalatine FossaCluster HeadacheElectric Stimulation TherapyRadiography Interventional03 medical and health sciences0302 clinical medicinemedicineHumansPain ManagementInsertion procedure030212 general & internal medicineDental implantNeurostimulationsphenopalatine ganglionPterygopalatine fossaPain Measurementbusiness.industryCluster headachepterygopalatine fossacluster headacheGanglia ParasympatheticPerioperativeEquipment DesignCone-Beam Computed Tomographymedicine.diseaseGanglionSurgerymedicine.anatomical_structureOtorhinolaryngologyneuromodulationSurgeryOral SurgerybusinessTomography X-Ray Computed030217 neurology & neurosurgeryneurostimulation
researchProduct

LO3 : Safety and efficacy of the combination daclatasvir-sofosbuvir in HCV genotype 1-mono-infected patients from the french observational cohort ANR…

2015

International audience; no abstract

medicine.medical_specialtyDaclatasvirHepatologySofosbuvir[ SDV ] Life Sciences [q-bio]business.industry[SDV]Life Sciences [q-bio]3. Good healthHcv genotype 1Internal medicineCohortMedicineObservational studybusinessComputingMilieux_MISCELLANEOUSmedicine.drug
researchProduct

Long-term effectiveness of agalsidase alfa enzyme replacement in Fabry disease: A Fabry Outcome Survey analysis

2015

Outcomes from 5 years of treatment with agalsidase alfa enzyme replacement therapy (ERT) for Fabry disease in patients enrolled in the Fabry Outcome Survey (FOS) were compared with published findings for untreated patients with Fabry disease. Data were extracted from FOS, a Shire-sponsored database, for comparison with data from three published studies. Outcomes evaluated were the annualized rate of change in estimated glomerular filtration rate (eGFR) and left ventricular mass indexed to height (LVMI) as well as time to and ages at a composite morbidity endpoint and at death. FOS data were extracted for 740 treated patients who were followed for a median of ~ 5 years. Compared with no trea…

medicine.medical_specialtyEndocrinology Diabetes and MetabolismUrologyCardiomyopathyRenal functionSE Standard errorLeft ventricular hypertrophyBiochemistryLVH Left ventricular hypertrophyLong-term effectivenessEndocrinologyGeneticsMedicineMDRD Modification of Diet in Renal Diseaselcsh:QH301-705.5Molecular BiologyAgalsidase alfaeGFR Estimated glomerular filtration rateFabry diseaselcsh:R5-920CI Confidence intervalbusiness.industryEnzyme replacement therapymedicine.diseaseEgfr Estimated glomerular filtration rateFabry diseaseSurgeryARB Angiotensin receptor blockerSEM Standard error of the meanStandard errorlcsh:Biology (General)SI:TherapyEnzyme replacement therapyCohortFOS Fabry Outcome SurveyLVMI Left ventricular mass indexed to heightlcsh:Medicine (General)businessACEI Angiotensin-converting enzyme inhibitorAgalsidase alfaERT Enzyme replacement therapyMolecular Genetics and Metabolism Reports
researchProduct

Endoscopic treatment of ectopic teeth in the maxillary sinus.

2020

Background Ectopic teeth in maxillary sinus is rare and are usually removed via sub-labial trans-canine fossa approach (SLCFA). The aim of our study was to present our experience with extraction of ectopic teeth in the maxillary sinus via transnasal endoscopic approach (TEA). Material and methods Rhinologists were asked to share their experience in the management of ectopic teeth in the maxillary sinus. Data were reviewed retrospectively. Results Eleven cases were reported in 10 patients from 2010 to 2019, six males and four females with a mean age of 33.5 +/-17 years (range 16 to 61). Seven patients complained of sinonasal symptoms, two were diagnosed incidentally during routine dental wor…

medicine.medical_specialtyFossabiologyMaxillary sinusbusiness.industryFistulamedicine.medical_treatmentResearchCheekbiology.organism_classificationmedicine.diseaseDentigerous cystSurgeryOperative Dentistry and Endodonticsstomatognathic diseasesmedicine.anatomical_structurestomatognathic systemmedicineCauterizationCystbusinessGeneral DentistrySinus (anatomy)UNESCO:CIENCIAS MÉDICASJournal of clinical and experimental dentistry
researchProduct

Magnetresonanztomographische Befunde nach Resektionsarthroplastik des Humeruskopfes

1995

PURPOSE The resection of the humeral head is normally carried out only with respect to four-part and dislocation fractures in elderly patients. The purpose of this study was to examine whether there is a correlation between the clinical results and the MRI findings. MATERIAL AND METHODS 8 patients underwent clinical and MR examination two to 6 years after resection. RESULTS A cartilage-like tissue formation between the remaining humeral head and the glenoid fossa, with signal intensities comparable to hyalin cartilage was found in all patients. CONCLUSION The good functional results following resectional surgery of the humeral head can partially be related to new substitute cartilage result…

medicine.medical_specialtyFossabiologybusiness.industrymedicine.medical_treatmentCartilagebiology.organism_classificationArthroplastyResectionSurgeryPlastic surgerymedicine.anatomical_structuremedicineUpper limbRadiology Nuclear Medicine and imagingNuclear medicinebusinessChondroid metaplasiaMri findingsRöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren
researchProduct

Induction of c-fos gene expression by the selective sigma receptor ligand EMD 57445 in rat brain.

1996

Based on animal studies it has been reasoned that ligands to sigma binding sites might be effective in the treatment of schizophrenic disorders and may also be used to investigate this largely elusive disorder on a molecular level. Expression patterns of c-fos in rat brain were studied following treatment with single doses of the sigma ligand EMD 57445 (0.3, 1, 3, 30 mg/kg s.c.). Specific c-fos gene expression was detected at all concentrations tested in various cortical areas. The signals observed were dose-dependent with the highest intensities in the piriform cortex. Strong signals were also detected in hippocampal areas CA 1,2,3 and the gyrus dentatus, as well as in the medial habenula …

medicine.medical_specialtyMammillary bodyNucleus accumbensHippocampal formationc-FosHippocampusRats Sprague-DawleyPiperidinesPiriform cortexInternal medicinemedicineAnimalsReceptors sigmaPharmacology (medical)OxazolesBiological PsychiatryIn Situ HybridizationPharmacologybiologyDose-Response Relationship DrugChemistryOlfactory tubercleBrainRatsPsychiatry and Mental healthEndocrinologyNeurologyHypothalamusIslands of Callejabiology.proteinFemaleNeurology (clinical)Proto-Oncogene Proteins c-fosAntipsychotic AgentsEuropean neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology
researchProduct

Canine fossa puncture in endoscopic sinus surgery: report of two cases

2017

Abstract Introduction Chronic rhinosinusitis with nasal polyposis is a common chronic disease that often affects maxillary sinus. Endoscopic sinus surgery is the most common procedure for treating the majority of maxillary sinus lesions. Objective To demonstrate the role of canine fossa puncture during endoscopic sinus surgery procedure in patients with severe maxillary sinus disease. Methods We present 2 cases where canine fossa puncture has been performed as method to obtain a complete access to the maxillary antrum. Results According our experience, 2 cases on 296 endoscopic sinus surgery (0.6%) where antrostomy and used of angled microdebrider were not sufficient, canine fossa puncture …

medicine.medical_specialtyMaxillary sinusChronic rhinosinusitissinusitisCanine fossa punctureMiddle meatal antrostomyPuncturesMaxillary antrumMaxillary sinusYoung Adult03 medical and health sciencesNasal Polyps0302 clinical medicineMaxillary sinusitisotorhinolaryngologic diseasesmedicineHumansIn patient030223 otorhinolaryngologyAgedMaxillary sinus sinusitis Maxillary sinusitisAlternative methodsAngled microdebriderbusiness.industryOtorhinolaryngology2734 Pathology and Forensic MedicineEndoscopylcsh:Otorhinolaryngologylcsh:RF1-547SurgeryEndoscopic sinus surgerymedicine.anatomical_structureChronic diseaseOtorhinolaryngologyCanine fossaAngled microdebrider; Canine fossa puncture; Maxillary sinusitis; Middle meatal antrostomy; Otorhinolaryngology2734 Pathology and Forensic MedicineChronic DiseaseFemaleTomography X-Ray Computedbusiness030217 neurology & neurosurgery
researchProduct

Effects of topical treatment with the raft modulator miltefosine and clobetasol in cutaneous mastocytosis: a randomized, double-blind, placebo-contro…

2009

Background Mastocytosis is characterized by the accumulation and activation of mast cells in different organs, most commonly the skin. Miltefosine, a raft modulator, has recently been shown to inhibit the activation of mast cells and to reduce mast cell-driven skin inflammatory responses. Objectives To study the safety and efficacy of topical miltefosine treatment of skin lesions in patients with mastocytosis. Methods Thirty-nine adult patients with mastocytosis with skin involvement were treated in a double-blind, placebo-controlled, parallel trial with topical miltefosine and clobetasol for 2 weeks. Treatment areas were analysed for changes in skin lesions and symptoms following mechanica…

medicine.medical_specialtyMiltefosinebusiness.industryCutaneous MastocytosisProvocation testPlacebo-controlled studyDermatologyMast cellDermatologylaw.inventionmedicine.anatomical_structurePharmacotherapyRandomized controlled trialDermislawMedicinebusinessmedicine.drugBritish Journal of Dermatology
researchProduct